HSH761 - Health Technology Assessment 1
Unit details
| Year: | 2020 unit information |
|---|---|
| Important Update: | Classes and seminars in Trimester 2/Semester 2, 2020 will be online. Physical distancing for coronavirus (COVID-19) will affect delivery of other learning experiences in this unit. Please check your unit sites for announcements and updates one week prior to the start of your trimester or semester. Last updated: 2 June 2020 |
| Enrolment modes: | Trimester 2: Burwood (Melbourne), Online |
| Credit point(s): | 1 |
| EFTSL value: | 0.125 |
| Unit Chair: | Trimester 2: Marcus Tan |
| Prerequisite: | HSH746 |
| Corequisite: | Nil |
| Incompatible with: | Nil |
| Typical study commitment: | Students will on average spend 150 hours over the teaching period undertaking the teaching, learning and assessment activities for this unit. |
| Scheduled learning activities - campus: | Seminars will be fortnightly in 2 x 2 hour blocks commencing week 1 of the trimester |
| Scheduled learning activities - cloud: | 1 hour weekly class (recording provided) and 1 hour weekly seminar exercise posted to a moderated online discussion group |
Content
Health technologies such as medicines, diagnostic tools and surgical procedures provide the opportunity for government and providers to improve health care services and patient outcomes. Given the rapid development of these technologies and expanding evidence for pre-existing interventions, decision-makers face unprecedented challenges in ensuring that high quality and innovative care is managed in an environment of scarce resources. Health Technology Assessment (HTA) provides a means by which health technologies can be assessed and prioritised against existing health care interventions to inform the benefits and comparative value of interventions. This unit will focus on HTA and the clinical evaluation process, including the role of evidence- based medicine in the decision-making process. Appraisal of clinical evidence will include ‘risk of bias’ assessment, heterogeneity across clinical trials, and the use of surrogate outcome measures, and how clinical evidence can be incorporated into economic evaluations.
|
| These are the Learning Outcomes (ULO) for this Unit | Deakin Graduate Learning Outcomes |
| ULO1 | Demonstrate knowledge of the current HTA processes (in Australia and internationally) including the relationship with subsidisation and purchasing schemes (for example PBS/MBS in Australia) and the registration of health technologies. | GLO1: Discipline-specific knowledge and capabilities |
| ULO2 | Describe a framework for the evaluation of health care technologies, including pharmaceuticals. | GLO1: Discipline-specific knowledge and capabilities |
| ULO3 | As a member of a team, design a protocol for a systematic review including the development of a search strategy with appropriate inclusion and exclusion criteria. | GLO2: Communication |
| ULO4 | Evaluate the risk of bias and potential sources of heterogeneity amongst identified trials and studies. | GLO1: Discipline-specific knowledge and capabilities |
| ULO5 | Analyse and interpret treatment effects via the use of summary statistics for dichotomous (Risk Ratio, Odds Ratio, Risk Difference), time to event (Hazard Ratio) and continuous (mean difference) outcomes; as well as the application of additional statistical methods such as meta-analyses and indirect comparisons. | GLO1: Discipline-specific knowledge and capabilities |
| ULO6 | Present evidence from a systematic review in a manner that appropriately communicates the results and encapsulates the main issues of consideration for decision makers. | GLO1: Discipline-specific knowledge and capabilities |
Assessment
Trimester 2:| Assessment Description | Student output | Grading and weighting | Indicative due week |
| Assessment 1: Contribution to online discussion topics |
| 20% |
|
| Assessment 2: Group Activity - literature search report | Individual contribution 1000 words | 20% |
|
| Assessment 3: Clinical Evaluation Report Part 1 | 1750 words | 35% |
|
| Assessment 4: Clinical Evaluation Report Part 2 | 1250 words | 25% |
|
The assessment due weeks provided may change. The Unit Chair will clarify the exact assessment requirements, including the due date, at the start of the teaching period.
Learning Resource
There is no prescribed text. Unit materials are provided via the unit site. This includes unit topic readings and references to further information.
Unit Fee Information
Click on the fee link below which describes you: